$460,000 of EXELIXIS INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Proposals related to drug pricing, including implementation of related provisions of the Inflation Reduction Act. Administration of the 340B Drug Pricing Program. PBM reform proposals. The Help Ensure Lower Patient (HELP) Copays Act. Intellectual property proposals relating to life sciences. S.5028, The Small Business Biotech Act.
IRC Section 174 amortization of R&D expenditures"
You can find more data on corporate lobbying on Quiver Quantitative.
EXEL Insider Trading Activity
EXEL insiders have traded $EXEL stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $EXEL stock by insiders over the last 6 months:
- JEFFREY HESSEKIEL (EVP & General Counsel) has made 0 purchases and 6 sales selling 260,000 shares for an estimated $7,869,350.
- DANA AFTAB (CSO/EVP Disc & Trans Research) has made 0 purchases and 4 sales selling 214,031 shares for an estimated $6,371,090.
- CHRISTOPHER J. SENNER (EVP and CFO) sold 125,000 shares for an estimated $3,398,750
- PATRICK J. HALEY (EVP, Commercial) has made 0 purchases and 4 sales selling 65,588 shares for an estimated $2,138,522.
- GEORGE POSTE has made 0 purchases and 2 sales selling 63,725 shares for an estimated $1,926,865.
- MARIA C FREIRE sold 8,250 shares for an estimated $219,120
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EXEL Hedge Fund Activity
We have seen 223 institutional investors add shares of EXEL stock to their portfolio, and 199 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FULLER & THALER ASSET MANAGEMENT, INC. added 4,700,717 shares (+211.6%) to their portfolio in Q3 2024, for an estimated $121,983,606
- LSV ASSET MANAGEMENT added 2,338,649 shares (+40.6%) to their portfolio in Q3 2024, for an estimated $60,687,941
- FARALLON CAPITAL MANAGEMENT LLC removed 1,692,000 shares (-6.2%) from their portfolio in Q3 2024, for an estimated $43,907,400
- ACADIAN ASSET MANAGEMENT LLC added 1,571,868 shares (+343.3%) to their portfolio in Q3 2024, for an estimated $40,789,974
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,507,004 shares (+313.6%) to their portfolio in Q3 2024, for an estimated $39,106,753
- BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC removed 1,467,748 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $38,088,060
- BLACKROCK, INC. removed 1,425,810 shares (-4.3%) from their portfolio in Q3 2024, for an estimated $36,999,769
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
